Arch Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Arch Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
  • Arch Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.02M, a 0.7% decline year-over-year.
  • Arch Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$4.72M, a 8.43% increase year-over-year.
  • Arch Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$5.04M, a 11.6% increase from 2022.
  • Arch Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$5.71M, a 10.5% increase from 2021.
  • Arch Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$6.38M, a 19.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$5.04M +$664K +11.6% Oct 1, 2022 Sep 30, 2023 10-K 2024-02-15
2022 -$5.71M +$668K +10.5% Oct 1, 2021 Sep 30, 2022 10-K 2024-02-15
2021 -$6.38M -$1.03M -19.2% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-28
2020 -$5.35M +$1.02M +16% Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2019 -$6.37M +$1.08M +14.5% Oct 1, 2018 Sep 30, 2019 10-K 2020-12-11
2018 -$7.45M -$147K -2.02% Oct 1, 2017 Sep 30, 2018 10-K 2019-11-19
2017 -$7.3M -$1.25M -20.7% Oct 1, 2016 Sep 30, 2017 10-K 2018-12-18
2016 -$6.05M -$590K -10.8% Oct 1, 2015 Sep 30, 2016 10-K 2017-11-15
2015 -$5.46M -$849K -18.4% Oct 1, 2014 Sep 30, 2015 10-K 2016-12-05
2014 -$4.61M -$2.87M -164% Oct 1, 2013 Sep 30, 2014 10-K 2015-12-11
2013 -$1.74M -$1.32M -315% Oct 1, 2012 Sep 30, 2013 10-K 2014-12-12
2012 -$421K Oct 1, 2011 Sep 30, 2012 10-K/A 2014-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.